Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.62 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | XBP1 | P17861 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.43 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.43 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1618053 | 1.00 | LMNA (0.65) | LMNAKDM4EAPOBEC3AAPOBEC3GGAA | |
| SCHEMBL14580754 | 1.00 | LMNA (0.65) | LMNAKDM4EAPOBEC3AAPOBEC3GGAA | |
| SCHEMBL10014116 | 1.00 | LMNA (0.65) | LMNAKDM4EAPOBEC3AAPOBEC3GGAA | |
| SCHEMBL14565715 | 1.00 | LMNA (0.65) | LMNAKDM4EAPOBEC3AAPOBEC3GGAA | |
| SCHEMBL1618051 | 1.00 | LMNA (0.65) | LMNAKDM4EAPOBEC3AAPOBEC3GGAA | |
| SCHEMBL1617431 | 1.00 | LMNA (0.65) | LMNAKDM4EAPOBEC3AAPOBEC3GGAA | |
| SCHEMBL15144383 | 1.00 | LMNA (0.65) | LMNAKDM4EAPOBEC3AAPOBEC3GGAA | |
| SCHEMBL110177 | 1.00 | LMNA (0.65) | LMNAKDM4EAPOBEC3AAPOBEC3GGAA | |
| SCHEMBL4749641 | 1.00 | LMNA (0.65) | LMNAKDM4EAPOBEC3AAPOBEC3GGAA | |
| SCHEMBL19809887 | 1.00 | LMNA (0.65) | LMNAKDM4EAPOBEC3AAPOBEC3GGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10028920-B2 | Methods for treating occular irritation involving tearing by administering modulators of TRPM8 | UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE (ES) | 2018-07-24 | — | — | US | disclosed |
| US-10028920-B2 | Methods for treating occular irritation involving tearing by administering modulators of TRPM8 | UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE (ES) | 2018-07-24 | — | — | US | disclosed |
| US-9901549-B2 | Method for treating vaginal dryness by administering transient receptor potential cation channel subfamily M member 8 (TRPM8) receptor agonists | UNIVERSIDAD MIGUEL HERNÁNDEZ DE ELCHE (ES) | 2018-02-27 | — | — | US | disclosed |
| US-20170071875-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS C.S.I.C. (ES) | 2017-03-16 | — | — | US | disclosed |
| US-20170071875-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS C.S.I.C. (ES) | 2017-03-16 | — | — | US | disclosed |
| US-20170049728-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS C.S.I.C. (ES) | 2017-02-23 | — | — | US | disclosed |
| US-20170049728-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS C.S.I.C. (ES) | 2017-02-23 | — | — | US | disclosed |
| US-9433679-B2 | Use of TRMP8 for treating opthalmic diseases or conditions involving tearing | UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE (ES) | 2016-09-06 | — | — | US | disclosed |
| US-9433679-B2 | Use of TRMP8 for treating opthalmic diseases or conditions involving tearing | UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE (ES) | 2016-09-06 | — | — | US | disclosed |
| US-20150313854-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE (ES) | 2015-11-05 | — | — | US | disclosed |
| US-20150313854-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE (ES) | 2015-11-05 | — | — | US | disclosed |
| US-9095609-B2 | Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia | UNIVERSIDAD MIGUEL HERNÁNDEZ DE ELCHE (ES) | 2015-08-04 | — | — | US | disclosed |
| US-9095609-B2 | Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia | UNIVERSIDAD MIGUEL HERNÁNDEZ DE ELCHE (ES) | 2015-08-04 | — | — | US | disclosed |
| US-20130245231-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS C.S.I.C. (ES) | 2013-09-19 | — | — | US | disclosed |
| US-20130245231-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS C.S.I.C. (ES) | 2013-09-19 | — | — | US | disclosed |
| WO-2008138162-A1 | COMPOSITIONS AND THEIR USE | GIVAUDAN SA (CH) | 2008-11-20 | — | — | WO | disclosed |
| US-6956139-B2 | (1R, 2S, 5R)-3-1-menthoxyalkan-1-OL cooling sensate | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-10-18 | — | — | US | disclosed |
| US-20020198412-A1 | (1R, 2S, 5R)-3-1-menthoxyalkan-1-OL cooling sensate | GREEN CARTER B (US) | 2002-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10028920-B2 | Methods for treating occular irritation involving tearing by administering modulators of TRPM8 | TRPM8, TRPM5, TRPM7 | LMNA 3957/4885KDM4E 3563/4885APOBEC3A 4581/4885 |
| US-20170049728-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | TRPM8, TRPM7, TRPM5 | LMNA 3812/4885KDM4E 4269/4885APOBEC3A 4624/4885 |
| US-20020198412-A1 | (1R, 2S, 5R)-3-1-menthoxyalkan-1-OL cooling sensate | TAS1R1, TAS2R1, TAS1R3 | LMNA 3297/4885KDM4E 2626/4885APOBEC3A 4019/4885 |
| US-20150313854-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | TRPM8, TRPM7, TRPM5 | LMNA 3812/4885KDM4E 4269/4885APOBEC3A 4624/4885 |
| US-20170071875-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | TRPM8, TRPM7, TRPM5 | LMNA 3812/4885KDM4E 4269/4885APOBEC3A 4624/4885 |
| US-20130245231-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE | TRPM8, TRPM7, TRPM5 | LMNA 3812/4885KDM4E 4269/4885APOBEC3A 4624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.